Digital Health You Can Experience in Rheumatology – From VR to an AI Symptom Checker

Every breakthrough in medicine only changes lives when people understand it.

That’s why we create digital experiences that transform complex immunology into knowledge, confidence, and hope.

#BackToHealth is more than just a hashtag: It is the vision that unites everything we create.

At this year’s Nürnberg Digital Festival NUEDIGITAL we had the opportunity to make this ongoing work tangible for visitors — through four digital applications that connect research, patient education, and clinical innovation.

The journey started with Bone Eaters, developed within the Deutsche Forschungsgemeinschaft (DFG) – German Research Foundation funded TRR369 DIONE. It is a mobile serious game that explains molecular inflammatory mechanisms contributing to osteoporosis.

Next up was Inflammania 3D – “Catch me if you can”, which is currently being further developed as part of the DFG-funded SFB1755 CASCAID project and uses Roblox’s multiplayer gameplay to explain how CAR-T cell therapy can work in systemic lupus erythematosus.

Understanding a treatment is one thing. Preparing for it as a patient is quite another. CARSLE VR demonstrates how immersive virtual reality is already being used in clinical practice to support patient education before CAR T-cell therapy in autoimmune diseases.

People who suspect they may be suffering from a rheumatic condition were able to find out about the mobile symptom checker ‘Rheumatics’, which was developed and evaluated as part of the EU-funded SPIDeRR consortium. The app helps people to document their symptoms in a structured way and enables earlier, more informed discussions with healthcare professionals.

Four technologies. One shared direction:
Making complex immunology understandable.
Empowering patients.
Bringing innovation closer to everyday healthcare.

From explaining disease mechanisms and innovative therapies to supporting clinical decision-making and patient education, these digital tools demonstrate how interdisciplinary collaboration can translate cutting-edge immunology into meaningful health experiences.

The exhibition was curated by PD Dr Harriet Morf and Sandra Jeleazcov, whose work combines clinical rheumatology, translational immunology, science communication, digital health and patient-centred innovation. In this way, they build a bridge between research, clinical care and public engagement – making complex medical topics accessible, understandable and tangible.

TRR369 DIONE Retreat 2026

A year after our last retreat, the TRR369 DIONE consortium Met for a third time. This time at Schloss Hirschberg in Beilngries.

It was great to see how much progress everyone has made singe we last met. Two days of strong science on inflammatory bone diseases, bringing together doctoral students and PIs from across our German network, with talks covering the full range of approaches we use to understand inflammatory bone loss. Great discussions, useful feedback, and a chance to reconnect with the consortium in person.

Huge Thanks to everyone who organized this retreat and made it such a memorable one, in such a stunning setting, too. Already looking forward to the Next one!

Congratulations to Christiane Schirm!

The TRR369 DIONE consortium proudly congratulates Christine Schirm on receiving the Best Presentation Award at the Nachwuchsforschungspreissymposium during the DVO Congress OSTEOLOGIE 2026 in Frankfurt.

Christine impressed the jury with her presentation
“Establishing an in vitro approach to generate osteomorphs.”

The award session, organized by DGO, DAdorW and MuSkITYRs, highlights outstanding early-career research in bone biology.

We are proud to see researchers from the TRR369 DIONE network driving innovation in osteoimmunology and receiving recognition for their excellent work.
👏 Congratulations, Christine!

DIONE brings science communication to life by presenting the interactive game BoneEaters

Developed within TRR369 DIONE, Bone Eaters transforms current research on the interaction between bone and immune cells into a playable experience.

Players explore how inflammation shapes bone biology and discover key mechanisms of osteoimmunology through gameplay.

By combining cutting-edge biomedical research with digital storytelling, the game opens new ways to make complex science tangible and engaging.

We are excited to bring the discoveries of TRR369 DIONE beyond the lab and into interactive formats that invite people to explore science themselves.

Download the app and play …
Google Play Store https://lnkd.in/eH3mfvNv

App Store https://lnkd.in/enp2Bcxp

 

TRR369 DIONE ScienceCommunication SeriousGames Osteoimmunology BoneResearch #OSTEOLOGIE2026
Bone Lab Dresden
Technische Universität Dresden
Universitätsklinikum Carl Gustav Carus Dresden
Universitätsklinikum Erlangen
FAU Erlangen-Nürnberg
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.

How can inflammation of the skin spread to the joints?

One of our research groups at the Department of Medicine 3 at Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), has identified a mechanism that explains how psoriasis can extend beyond the skin and affect the joints.

The team (Maria Gabriella Raimondo, Andreas Ramming, Simon Rauber, and Hashem Mohammadian) was able to demonstrate for the first time which immune cells migrate from the skin to the joints and why these resident immune cells trigger inflammation once they have settled there.

These findings contribute to a better understanding of disease progression and may help pave the way for targeted therapies aimed at preventing the migration of inflammatory cells in the future.

 

https://www.medizin3.uk-erlangen.de/aktuelles/nachrichten/detail/wie-schuppenflechte-auf-die-gelenke-uebergreift/

Meet our Researcher: Theresa Schmid

What is your current position?

I am a doctoral researcher in the scientific laboratory of the Department of Orthodontics and Orofacial Orthopedics at Universitätsklinikum Erlangen where we investigate molecular and developmental mechanisms that contribute to orofacial diseases and shape craniofacial biology. I am part of the Transregio CRC 369 “DIONE – Degeneration of Bone due to Inflammation”.

 

What is your main research focus?

Within DIONE, my research explores how inflammatory processes — whether sterile or non-sterile — impact bone health. My research investigates how osteoclasts are shaped by a complex cellular microenvironment. Using advanced tissue-level bioimaging and niche-specific transcriptional profiling, our goal is to understand how these microenvironmental cues drive inflammation-induced bone loss in models of arthritis and periodontitis.

 

What does your typical workday look like?

My everyday work combines planning and conducting laboratory experiments with extensive data analysis. Outside the bench, I focus on interpreting results, preparing figures, and engaging in scientific discussions with colleagues.

Meet our Researcher: Kara Nachtnebel

What is your current position?

I work as a PhD student at a collaboration project between the Medicine 3 of  Uniklinikum Erlangen (Uderhardt lab) and the Max-Planck-Zentrum für Medizin und Physik (Zaburdaev lab). This collaboration allows me to work closely with colleagues from diverse backgrounds, ranging from medicine and biology to computer science and theoretical physics.

 

What is your main research focus?

Our research aims to uncover how cells communicate within intercellular networks. We are particularly interested in networks of osteocytes or interstitial fibroblast, which form intricate connections that allow cells to coordinate their functions and even share resources. A key focus of our work is on calcium signaling — a fundamental process through which cells exchange information. By combining experimental observations with mathematical modeling, we study how calcium signals propagate through these networks and how changes in network organization, such as those occurring in disease, can disrupt communication. Ultimately, this approach helps us better understand how cellular miscommunication contributes to tissue dysfunction and pathology.

 

What does your typical workday look like?

As a member of two distinct research groups, I need to organize my work accordingly. Typically, my schedule includes meetings and talks. Before and after these appointments, I am free to engage in self-organized work, such as reading the literature, adjusting code, creating plots and figures, and writing.

Meet our Researcher: Dr. Carina Scholtysek

What is your current position?

I am a Research Group Leader for Osteo- and Dentalimmunology. Within DIONE, I collaborate with Dr. Ulrike Baschant on project A05: “Investigating the role of iron in inflammation-induced bone loss: insights into osteoclast metabolism.”

What is your main research focus?

My group investigates the intracellular metabolism of immune and bone cells, with a strong emphasis on how metabolic reprogramming and altered bioenergetics drive inflammation and bone destruction. We are particularly interested in the crosstalk between bone and immune cells, aiming to unravel how their interactions shape the course of inflammatory and degenerative diseases.

Another key aspect of our work is the oral microbiome and its contribution to the pathogenesis of autoimmune diseases. By understanding these mechanisms, we hope to identify novel strategies for both prevention and therapy.

What does your typical workday look like?

My key task is to create an environment where my team can work efficiently by taking care of challenges behind the scenes. I spend my days mentoring PhD students, keeping projects on track, collaborating with clinical partners, and dedicating time to developing grant proposals and publications. What makes an ordinary day truly exciting are new collaborations, setting up novel experiments and models, and celebrating shared successes with the team.

Meet our Researcher: Dr. Martina Rauner

What is your current position?

I am Professor of Molecular Bone Biology and scientific director of the Bone Lab at the Medical Faculty of the Technical University of Dresden. I also serve as the co-speaker of the Transregio CRC 369 “DIONE – Degeneration of Bone due to Inflammation” and as the speaker of the research unit FOR 5146 “FerrOsOsteohepatic axis and bone”.

What is your main research focus?

We focus on understanding the cellular and molecular mechanisms of bone diseases related to inflammation, hormonal dysregulation, hematological disorders and malignancy. We focus on signaling pathways including BMP and Wnt signaling, FGF-23 as well as dysregulations in cellular metabolism.

What does your typical workday look like?

On most days, lots of emails for organizing and coordinating activities that are related to science, administrative and organizational aspects, or work for scientific societies and committees of our faculty. The most fun part though is talking to the scientists about their work, writing/correcting manuscripts, and writing grant proposals.

Meet our Researcher: Dr. Ulrike Steffen

What is your current position?

I am research group leader the Department of Medicine 3 – Rheumatology & Immunology at Friedrich‑Alexander‑University and Uniklinikum Erlangen. I also serve as steering committee member of the Transregio CRC 369 “DIONE – Degeneration of Bone due to Inflammation”.

What is your main research focus?

My research team investigates the mechanisms underlying the development of autoimmunity and the interplay of autoantibodies, innate immune cells, and bone loss in rheumatologic diseases.

We focus on:

  • Plasma cell development, antibody characteristics and the impact of glycosylation in (auto)immunity
  • Regulation of osteoclast activity and bone homeostasis

What does your typical workday look like?

A typical day starts with a well structured to-do list that becomes totally crashed within the first hour. The rest of the day is a mixture of problem solving, experimental design, many discussions with my research team and collaborators, writing and occasional celebrations of breakthroughs.

Meet our Researcher: Dr. Darja Andreev

What is your current position?

I am a group leader focused on tissue regeneration and the resolution of inflammation at the Center for Regenerative Therapies Dresden (CRTD), part of Technische Universität Dresden (TUD). I am actively involved in teaching within the Master’s program Regenerative Biology and Medicine.

Within the Transregio CRC 369 “DIONE – Degeneration of Bone due to Inflammation,” I lead project B03, which investigates the protective role of eosinophils in bone loss associated with inflammatory arthritis.

What is your main research focus?

My research focuses on the often overlooked homeostatic and regulatory roles of eosinophils, exploring how these cells, traditionally viewed as pro-inflammatory effectors, also contribute to the resolution of inflammation and tissue regeneration across multiple organs. Building on our discoveries of regulatory eosinophil populations in joints and bone marrow, we investigate how tissue microenvironments shape eosinophil phenotypes at metabolic, epigenetic, and proteomic levels. Our long-term goal is to reprogram eosinophils toward a tissue-protective, pro-resolving state to improve outcomes in chronic inflammatory diseases.

What does your typical workday look like?

I recently launched my own research group in Dresden and the first months have been all about building a lab from the ground up and getting our science rolling. These days, my routine is a mix of mentoring amazing PhD, master’s, and bachelor’s students, staying hands-on at the bench, analyzing data, leading lab meetings, collaborating with clinical partners, and advancing grants and publications. I also teach in the Master’s program Regenerative Biology and Medicine, where I get to share why immunology is such a powerful field and how it shapes our fight against chronic inflammatory diseases.